Pancreatic Ductal Adenocarcinoma Clinical Trials in Scottsdale, Arizona
5 studies are recruiting for pancreatic ductal adenocarcinoma in Scottsdale, Arizona right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this study are to: * Find the recommended dose of ART0380 that can be given safely to participants alone and in combination with gemcitabine or irinotecan * Learn more…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Mayo Clinic (Arizona), Scottsdale, Arizona
- Locations
- 82 in total
- Run by
- Artios Pharma Ltd
-
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON) inhibitors combined with Standard(s) of Care (SOC) or with novel agents. The current subprotocols include the following: Subprotocol A: RMC-6236 + 5…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- HonorHealth Research Institute, Scottsdale, Arizona
- Locations
- 32 in total
- Run by
- Revolution Medicines, Inc.
-
Pancreatic Cancer Early Detection Consortium
The purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal adenocarcinoma (PDAC) by establishing a multisite cohort of individuals with family history of PDAC and/or individuals carrying…
- Stage
- Not phased
- Ages
- 18 to 90
- Site
- Honor Health Research Institute, Scottsdale, Arizona
- Locations
- 60 in total
- Run by
- Arbor Research Collaborative for Health
-
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like your lungs or liver instead of your blood. Once tumors have grown bigger in one place but haven't spread, they're called locally advanced. If your cancer has spread to other parts …
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Mayo Clinic, Scottsdale, Arizona
- Locations
- 48 in total
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
-
Pancreatic Cancer Detection Consortium
This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Honorhealth, Scottsdale, Arizona
- Locations
- 11 in total
- Run by
- City of Hope Medical Center
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.